Is triptan (Triptans), a class of medications, FDA (Food and Drug Administration) approved for the treatment of tension-type headaches?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

No, triptans are not FDA approved for tension headaches. The most recent and highest quality study, 1, published in 2025, does not mention the use of triptans for tension headaches. Instead, it recommends the use of NSAIDs, acetaminophen, or combination therapy for the treatment of acute episodic migraine headache.

  • Triptans, such as sumatriptan (Imitrex), rizatriptan (Maxalt), and zolmitriptan (Zomig), are specifically approved for the treatment of migraine headaches and, in some cases, cluster headaches.
  • Tension headaches typically respond better to over-the-counter pain relievers like acetaminophen, ibuprofen, or aspirin.
  • The reason triptans aren't approved for tension headaches relates to their mechanism of action - they work by stimulating serotonin receptors that cause blood vessels to constrict and reduce inflammation in the brain, which is effective for migraines but not the pathophysiology of tension headaches.
  • Tension headaches are believed to result from muscle contraction and stress, rather than the neurovascular changes seen in migraines.
  • Using triptans for tension headaches would be considered off-label use and isn't supported by strong clinical evidence, as stated in 1 and 1.
  • For persistent tension headaches, treatments like muscle relaxants, certain antidepressants, or stress management techniques may be more appropriate, as suggested by 1 and 1.

From the Research

Triptan FDA Approval for Tension Headaches

  • The FDA approval status of triptans for tension headaches is not explicitly stated in the provided studies 2, 3, 4, 5, 6.
  • However, it is mentioned that triptans are primarily used for the treatment of migraines, and their effectiveness in other types of headaches, including tension headaches, is still being researched 2.
  • There are limited controlled clinical data to support the use of triptans for tension headaches, but some reports suggest that they may be effective in stopping attacks of tension-type headaches 2.
  • The studies provided focus on the use of triptans for migraines, and do not provide conclusive evidence on their FDA approval for tension headaches.

Available Information on Triptans

  • Triptans are a class of medications that are specifically approved for the treatment of migraines 2.
  • They are serotonin (5-HT1B/1D) receptor agonists that are generally effective, well-tolerated, and safe 2.
  • Seven triptans are available worldwide, with multiple routes of administration, giving doctors and patients a wide range of choices 2.
  • Triptans are not pain medications, but rather abortive migraine medications that cannot prevent migraines 2.

Research on Triptans and Tension Headaches

  • There is limited research on the use of triptans for tension headaches, and more studies are needed to determine their effectiveness and safety for this condition 2, 3, 4, 5, 6.
  • Some studies suggest that triptans may be effective in stopping attacks of tension-type headaches, but more research is needed to confirm these findings 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Triptans: over the migraine.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2012

Research

[Update on Current Care Guideline: Headache (children)].

Duodecim; laaketieteellinen aikakauskirja, 2016

Research

Medical Treatment Guidelines for Acute Migraine Attacks.

Acta neurologica Taiwanica, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.